OSAM
REGN icon

O'Shaughnessy Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.86M Sell
9,404
-3,852
-29% -$2.62M 0.03% 509
2026
Q1 		$10.2M Buy
13,256
+2,761
+26% +$2.11M 0.05% 372
2025
Q4 		$8.1M Buy
10,495
+3,506
+50% +$2.38M 0.04% 398
2025
Q3 		$3.93M Buy
6,989
+1,896
+37% +$1.07M 0.02% 586
2025
Q2 		$2.67M Sell
5,093
-2,128
-29% -$1.19M 0.02% 671
2025
Q1 		$4.58M Buy
7,221
+1,074
+17% +$739K 0.04% 450
2024
Q4 		$4.38M Sell
6,147
-2,634
-30% -$2.21M 0.04% 447
2024
Q3 		$8.91M Buy
8,781
+879
+11% +$978K 0.08% 270
2024
Q2 		$8.31M Buy
7,902
+982
+14% +$952K 0.09% 262
2024
Q1 		$6.66M Buy
6,920
+1,030
+17% +$979K 0.07% 295
2023
Q4 		$5.17M Buy
5,890
+153
+3% +$126K 0.07% 303
2023
Q3 		$4.72M Buy
5,737
+2,553
+80% +$2.01M 0.07% 296
2023
Q2 		$2.29M Sell
3,184
-203
-6% -$157K 0.03% 423
2023
Q1 		$2.78M Buy
3,387
+26
+0.8% +$19.6K 0.04% 385
2022
Q4 		$2.42M Buy
3,361
+350
+12% +$258K 0.04% 390
2022
Q3 		$2.07M Buy
3,011
+1,400
+87% +$881K 0.04% 385
2022
Q2 		$952K Buy
1,611
+309
+24% +$201K 0.02% 537
2022
Q1 		$909K Buy
1,302
+533
+69% +$337K 0.02% 554
2021
Q4 		$486K Sell
769
-48
-6% -$29.5K 0.01% 700
2021
Q3 		$495K Buy
817
+256
+46% +$159K 0.01% 651
2021
Q2 		$313K Buy
561
+36
+7% +$18.2K 0.01% 838
2021
Q1 		$248K Sell
525
-93
-15% -$45.3K 0.01% 840
2020
Q4 		$299K Sell
618
-29
-4% -$15.7K 0.01% 692
2020
Q3 		$362K Buy
647
+29
+5% +$17.6K 0.01% 527
2020
Q2 		$385K Buy
618
+530
+602% +$301K 0.01% 465
2020
Q1 		$43K Sell
88
-9
-9% -$3.71K ﹤0.01% 808
2019
Q4 		$36K Buy
+97
New +$32.6K ﹤0.01% 1027

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

O'Shaughnessy Asset Management's REGN Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q2 2026, selling an estimated $2.62M and leaving 9,404 shares worth $5.86M. The position accounts for 0.03% of the portfolio, ranked #509.

O'Shaughnessy Asset Management first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.2M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • O'Shaughnessy Asset Management held 9,404 shares of Regeneron Pharmaceuticals worth $5.86M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 3,852 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.62M.
  • Regeneron Pharmaceuticals made up 0.03% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #509 holding.
  • O'Shaughnessy Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • O'Shaughnessy Asset Management's Regeneron Pharmaceuticals position peaked at $10.2M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.